Canaccord Genuity Group Inc (TSX:CF) is set to release its Q3 2025 earnings on Feb 5, 2025. The consensus estimate for Q3 ...
2h
Hosted on MSNCanaccord Genuity Downgrades Pliant Therapeutics (PLRX)Fintel reports that on February 10, 2025, Canaccord Genuity downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) ...
Despite a 16% revenue increase, Canaccord Genuity Group Inc (CCORF) faces profitability hurdles due to rising expenses and US ...
Investment analysts at Ventum Cap Mkts dropped their FY2025 earnings per share (EPS) estimates for shares of Canaccord ...
In a report released on February 7, Alex Brooks from Canaccord Genuity reiterated a Buy rating on Invinity Energy Systems (IES – Research ...
In a report released today, Owen Humphries from Canaccord Genuity maintained a Buy rating on Temple & Webster Group Ltd (TPLWF – Research ...
Illumina (NASDAQ:ILMN – Free Report) had its price objective cut by Canaccord Genuity Group from $145.00 to $135.00 in a report published on Friday,Benzinga reports. They currently have a hold rating ...
Canaccord Genuity Group Inc. (TSE:CF) will pay a dividend of CA$0.085 on the 13th of March. Based on this payment, the dividend yield on the company's stock will be 4.0%, which is an attractive boost ...
Global (NYSE:SPIR) and increased the price target to $24 from the previous $18. With the stock currently trading at $20.15 ...
CA$0.23 loss per share (down from CA$0.15 profit in 3Q 2024). All figures shown in the chart above are for the trailing 12 ...
CEO Dan Daviau emphasized optimism for fiscal 2026, driven by recovery in mid-market equities and continued strength in wealth management contributions. He highlighted the M&A market as one of the ...
Uncertainty around North American trade has hindered capital-markets activity and stalled investments in Canada, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results